Hilden, Germany and Germantown, MD 1/9/17—Life sciences solutions firm QIAGEN has acquired OmicSoft, a provider of –omics data management and interpretation software, for cash. Financial details were not disclosed. OmicSoft’s solutions enables scientists to analyze and visualize their own data sets as well as compare them with publicly available omics data sets, including curated omics data for unpublished findings. “The market opportunity is significant given the expanding use of multiple ‘omics’ data in research and clinical healthcare. We intend to integrate the OmicSoft solutions into our full bioinformatics interpretation portfolio, and make it a key differentiator in our Sample to Insight offerings,” stated Dr. Laura Furmanski, senior Vice President and head of the Bioinformatics Business Area at QIAGEN. QIAGEN anticipates the acquisition to add approximately half a percentage point to incremental sales growth and to be neutral to adjusted EPS. OmicSoft Cofounder and President Dr. Jack Liu will remain with the company.

QIAGEN’s bioinformatics business has primarily focused on NGS data, but this acquisition adds: capabilities for analyzing and integrating other omics data, new data sharing options, and a flexible software architecture to enable future expansion. OmicSoft’s Array Studio consists of: Land technology for use with public data sets; Array Server, an enterprise back-end solution; and Array Studio, a graphical user interface for omics data, including NGS and microarray data.